Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Stroke | Research

Burden of stroke in North Africa and Middle East, 1990 to 2019: a systematic analysis for the global burden of disease study 2019

Authors: Ataollah Shahbandi, Parnian Shobeiri, Sina Azadnajafabad, Sahar Saeedi Moghaddam, Yeganeh Sharifnejad Tehrani, Narges Ebrahimi, Nazila Rezaei, Mohammad-Mahdi Rashidi, Seyyed-Hadi Ghamari, Mohsen Abbasi-Kangevari, Sogol Koolaji, Rosa Haghshenas, Negar Rezaei, Bagher Larijani, Farshad Farzadfar

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

While several studies investigated the epidemiology and burden of stroke in the North Africa and Middle East region, no study has comprehensively evaluated the age-standardized attributable burden to all stroke subtypes and their risk factors yet.

Objective

The aim of the present study is to explore the regional distribution of the burden of stroke, including ischemic stroke, subarachnoid hemorrhage, and intracerebral hemorrhage, and the attributable burden to its risk factors in 2019 among the 21 countries of North Africa and Middle East super-region.

Methods

The data of the Global Burden of Disease Study (GBD) 2019 on stroke incidence, prevalence, death, disability-adjusted life years (DALYs), years of life lost (YLLs), years lived with disability (YLDs) rates, and attributed deaths, DALYs, YLLs, and YLDs to stroke risk factors were used for the present study.

Results

The age-standardized deaths, DALYs, and YLLs rates were diminished statistically significant by 27.8, 32.0, and 35.1% from 1990 to 2019, respectively. Attributed deaths, DALYs, and YLLs to stroke risk factors, including high systolic blood pressure, high body-mass index, and high fasting plasma glucose shrank statistically significant by 24.9, 25.8, and 28.8%, respectively.

Conclusion

While the age-standardized stroke burden has reduced during these 30 years, it is still a concerning issue due to its increased burden in all-age numbers. Well-developed primary prevention, timely diagnosis and management of the stroke and its risk factors might be appreciated for further decreasing the burden of stroke and its risk factors and reaching Sustainable Development Goal 3.4 target for reducing premature mortality from non-communicable diseases.
Appendix
Available only for authorised users
Literature
1.
2.
Campbell BC, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke. Nature Reviews Disease Primers. 2019;5(1):71.CrossRef
3.
4.
5.
Wafa HA, Wolfe CD, Emmett E, Roth GA, Johnson CO, Wang Y. Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years. Stroke. 2020;51(8):2418–27.PubMedPubMedCentralCrossRef
6.
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–22.CrossRef
7.
8.
9.
Sibai AM, Nasreddine L, Mokdad AH, Adra N, Tabet M, Hwalla N. Nutrition transition and cardiovascular disease risk factors in Middle East and North Africa countries: reviewing the evidence. Annals of Nutrition and Metabolism. 2010;57(3–4):193–203.CrossRef
10.
Galimanis A, Mono M-L, Arnold M, Nedeltchev K, Mattle HP. Lifestyle and stroke risk: a review. Curr Opin Neurol. 2009;22(1):60–8.PubMedCrossRef
11.
Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med. 2011;171(20):1811–8.PubMedCrossRef
12.
13.
Tran J, Mirzaei M, Anderson L, Leeder SR. The epidemiology of stroke in the Middle East and North Africa. J Neurol Sci. 2010;295(1):38–40.PubMedCrossRef
14.
Rukn SA, Mazya MV, Hentati F, Sassi SB, Nabli F, Said Z, et al. Stroke in the middle-east and North Africa: a 2-year prospective observational study of stroke characteristics in the region—results from the safe implementation of treatments in stroke (SITS)–middle-east and north African (MENA). Int J Stroke. 2019;14(7):715–22.PubMedCrossRef
15.
Abd-Allah F, Moustafa RR. Burden of stroke in Egypt: current status and opportunities. Int J Stroke. 2014;9(8):1105–8.PubMedCrossRef
16.
Azarpazhooh MR, Etemadi MM, Donnan GA, Mokhber N, Majdi MR, Ghayour-Mobarhan M, et al. Excessive incidence of stroke in Iran: evidence from the Mashhad stroke incidence study (MSIS), a population-based study of stroke in the Middle East. Stroke. 2010;41(1):e3–e10.PubMedCrossRef
17.
Ibrahim F, Deleu D, Akhtar N, Al-Yazeedi W, Mesraoua B, Kamran S, et al. Burden of stroke in Qatar. J Stroke Cerebrovasc Dis. 2015;24(12):2875–9.PubMedCrossRef
18.
Djalalinia S, Saeedi Moghaddam S, Rezaei N, Rezaei N, Mansouri A, Abdolhamidi E, et al. National and sub-national patterns of mortality from stroke in the Iranian population (1990-2015): complementary results from the NASBOD study. Int J Stroke. 2020;15(2):132–48.PubMedCrossRef
19.
Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223–49.CrossRef
20.
World Health Organization. The international statistical classification of diseases and health related problems ICD-10: tenth revision. Volume 1: tabular list. Geneva: World Health Organization; 2004.
21.
Jaberinezhad M, Farhoudi M, Nejadghaderi SA, Alizadeh M, Sullman MJ, Carson-Chahhoud K, et al. The burden of stroke and its attributable risk factors in the Middle East and North Africa region, 1990–2019. Sci Rep. 2022;12(1):1–11.CrossRef
22.
Behrouz R, Powers CJ. Epidemiology of classical risk factors in stroke patients in the Middle East. Eur J Neurol. 2016;23(2):262–9.PubMedCrossRef
23.
Abd-Allah F, Khedr E, Oraby MI, Bedair AS, Georgy SS, Moustafa RR. Stroke burden in Egypt: data from five epidemiological studies. Int J Neurosci. 2018;128(8):765–71.PubMedCrossRef
24.
Kilpi F, Webber L, Musaigner A, Aitsi-Selmi A, Marsh T, Rtveladze K, et al. Alarming predictions for obesity and non-communicable diseases in the Middle East. Public Health Nutr. 2014;17(5):1078–86.PubMedCrossRef
25.
Farrag NS, Cheskin LJ, Farag MK. A systematic review of childhood obesity in the Middle East and North Africa (MENA) region: prevalence and risk factors meta-analysis. Adv Pediatr Res. 2017;4:8.PubMedPubMedCentral
26.
Majeed A, El-Sayed AA, Khoja T, Alshamsan R, Millett C, Rawaf S. Diabetes in the middle-east and North Africa: an update. Diabetes Res Clin Pract. 2014;103(2):218–22.PubMedCrossRef
27.
Yusufali AM, Khatib R, Islam S, Alhabib KF, Bahonar A, Swidan HM, et al. Prevalence, awareness, treatment and control of hypertension in four Middle East countries. J Hypertens. 2017;35(7):1457–64.PubMedCrossRef
28.
Motlagh B, O'Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009;16(3):268–80.PubMedCrossRef
29.
Lotfaliany M, Akbarpour S, Mozafary A, Boloukat RR, Azizi F, Hadaegh F. Hypertension phenotypes and incident cardiovascular disease and mortality events in a decade follow-up of a Middle East cohort. J Hypertens. 2015;33(6):1153–61.PubMedCrossRef
30.
Abboud M, Karam S. Hypertension in the Middle East: current state, human factors, and barriers to control. J Hum Hypertens. 2021;36:1–9.
31.
Meo SA, Sheikh SA, Sattar K, Akram A, Hassan A, Meo AS, et al. Prevalence of type 2 diabetes mellitus among men in the Middle East: a retrospective study. Am J Mens Health. 2019;13(3):1557988319848577.PubMedPubMedCentralCrossRef
32.
Countdown N. NCD Countdown 2030: Pathways to achieving sustainable development goal target 3.4. Lancet. 2020;396(10255):918.CrossRef
33.
Shambesh MKA, Emahbes TM, Saleh ZE, Elosta MAA, Shambesh IM. Role of hypertension as a major risk factor of stroke in africa; Libya: community based survey. Journal of advances in medicine and medical Research. 2015;9:1–11.CrossRef
34.
Hajat C, Harrison O, Al SZ. Weqaya: a population-wide cardiovascular screening program in Abu Dhabi, United Arab Emirates. Am J Public Health. 2012;102(5):909–14.PubMedPubMedCentralCrossRef
35.
Kickbusch I. Advancing the global health agenda. UN Chron. 2011;48(4):37–40.CrossRef
36.
Al Hashmi AM, Ozdemir AO, Shuaib A, Al-Jehani H, Mansour OY, Alhazzani A, et al. Current recommendations for the Management of Stroke Patients in the Middle East in the era of COVID-19 pandemic; statement from the MENA SINO. J Stroke Cerebrovasc Dis. 2020;29(11):105181.PubMedPubMedCentralCrossRef
37.
Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors J, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.PubMedCrossRef
38.
Mistry EA, Mistry AM, Nakawah MO, Chitale RV, James RF, Volpi JJ, et al. Mechanical thrombectomy outcomes with and without intravenous thrombolysis in stroke patients: a meta-analysis. Stroke. 2017;48(9):2450–6.PubMedCrossRef
39.
Raychev R, Saver JL. Mechanical thrombectomy devices for treatment of stroke. Neurology: clinical practice. 2012;2(3):231–5.
40.
41.
Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3· 0 million participants. Lancet. 2011;377(9765):578–86.PubMedCrossRef
42.
Teunissen LL, Rinkel GJ, Algra A, Van Gijn J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke. 1996;27(3):544–9.PubMedCrossRef
43.
44.
Muehlschlegel S. Subarachnoid hemorrhage. Continuum (Minneap Minn). 2018;24(6):1623–57.
45.
Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450–60.PubMedCrossRef
46.
47.
Elijovich L, Patel PV, Hemphill JC, editors. Intracerebral hemorrhage. Seminars in neurology. New York: © Thieme Medical Publishers; 2008.
48.
Jiang Y, Lu H, Man Q, Liu Z, Wang L, Wang Y, et al. Stroke burden and mortality attributable to ambient fine particulate matter pollution in 195 countries and territories and trend analysis from 1990 to 2017. Environ Res. 2020;184:109327.PubMedCrossRef
49.
Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368:904–13.PubMedPubMedCentralCrossRef
50.
51.
Sacco RL. Risk factors and outcomes for ischemic stroke. Neurology. 1995;45(2 Suppl 1):S10–4.PubMed
52.
Bogiatzi C, Hackam DG, McLeod AI, Spence JD. Secular trends in ischemic stroke subtypes and stroke risk factors. Stroke. 2014;45(11):3208–13.PubMedCrossRef
53.
Metadata
Title
Burden of stroke in North Africa and Middle East, 1990 to 2019: a systematic analysis for the global burden of disease study 2019
Authors
Ataollah Shahbandi
Parnian Shobeiri
Sina Azadnajafabad
Sahar Saeedi Moghaddam
Yeganeh Sharifnejad Tehrani
Narges Ebrahimi
Nazila Rezaei
Mohammad-Mahdi Rashidi
Seyyed-Hadi Ghamari
Mohsen Abbasi-Kangevari
Sogol Koolaji
Rosa Haghshenas
Negar Rezaei
Bagher Larijani
Farshad Farzadfar
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Stroke
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02793-0

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue

Case report

Whole-exome sequencing confirms implication of VPS13D as a potential cause of progressive spastic ataxia

Correction

Correction: Characteristics of people with epilepsy in three Eastern African countries – a pooled analysis

Case report

Autonomic dysfunction detected by skin sympathetic response in Lambert-Eaton myasthenic syndrome: a case report

Research

Predictors of recurrence of chronic subdural haematoma in a cohort study of patients presenting in a sub-Saharan African teaching hospital

Case report

 Reversible Pisa syndrome caused by chronic subdural hematoma in a patient with Parkinson’s disease: a case report

Research

Neuroanatomical regions associated with non-progressive dysarthria post-stroke: a systematic review